NSCLC Biomarkers: Current Landscape and Future Perspectives for Precision Medicine

View an on-demand Webcast of a live CCO Webinar and then download the slides to gain expert perspectives from a medical oncologist and pathologist on biomarker testing and personalized therapy in NSCLC, including review of the latest clinical data, key strategies for optimal biomarker detection, and communication among the multidisciplinary team.
Matthew Gubens, MD, MS
Sanjay Mukhopadhyay, MD

Downloadable Slidesets

Download this slideset on established and emerging biomarkers critical to optimal use of targeted therapy and immunotherapy in patients with NSCLC.

Matthew Gubens, MD, MS Released: September 11, 2020

Download this slideset for a pathologist’s perspective on testing for NSCLC biomarkers, including best practices for biopsy, selecting assays, and interpreting results.

Sanjay Mukhopadhyay, MD Released: September 11, 2020

Download this short summary slideset of key takeaways from a live CCO Webinar on testing for and leveraging biomarkers critical to optimal use of targeted therapy and immunotherapy in the treatment of NSCLC.

Matthew Gubens, MD, MS Sanjay Mukhopadhyay, MD Released: September 11, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Amgen
Merck Sharp & Dohme Corp

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue